E2f1-3 祖細胞の活性化剤から,分化細胞の抑制剤に切り替える
Jean-Leon Chong1, Pamela L Wenzel, M Teresa Sáenz-Robles
1Department of Molecular Virology, Immunology and Medical Genetics, College of Medicine, The Ohio State University, Columbus, Ohio 43210, USA.
Nature
|December 18, 2009
まとめ
網膜芽細胞腫タンパク質 (Rb) とE2f活性化剤 (E2f1-3) は,細胞周期制御において二重の役割を果たしています. E2f1-3は,親細胞の生存に不可欠であり,分裂ではなく,分化を抑制します.
科学分野:
- 細胞生物学 細胞生物学
- 分子生物学は分子生物学である.
- 遺伝学 遺伝学とは
背景:
- 網膜芽細胞腫タンパク質 (Rb) は,E2f活性化剤 (E2f1-3) を隔離することで,伝統的に細胞サイクル進行を阻害しています.
- E2f1-3は,細胞をS相と増殖に導く重要な効果因子と考えられています.
研究 の 目的:
- 哺乳類の細胞周期制御におけるE2f1,E2f2およびE2f3のインビボ機能を調査する.
- E2f1-3の活性化剤と抑制剤の文脈依存的な役割を明確にするために.
主な方法:
- 組織特異的なクレートランスジェニックマウスと条件付きE2fアレルを使用した.
- 試験されたE2f1-3トリプル欠乏症は,ネズミの胚性幹細胞,胚,小腸で確認された.
主要な成果:
- 先祖細胞の分裂において,E2f1-3は活性化剤として作用するが,生存に不可欠な分裂には欠かせない.
- 分化細胞では,E2f1-3がRbと複合してE2f標的を抑制し,細胞サイクル終了を促進します.
- 分化細胞におけるRb不活性化により,E2f1-3が活性化細胞に切り替えられ,子宮外分裂を引き起こした.
結論:
- E2f1-3は,細胞の文脈 (分裂対微分) に応じて,活性化剤または抑制剤として動的に機能する.
- E2f1-3は原始細胞の生存に不可欠であり,分化中の細胞サイクル終了において重要な役割を果たします.
- この研究では,E2f1-3が正常な細胞サイクルと異常な細胞サイクルにおける役割を再定義し,がん研究に影響を与えています.
関連する概念動画
RNA Polymerase II Accessory Proteins
Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
Master Transcription Regulators
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Master Transcription Regulators
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Co-activators and Co-repressors
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Co-activators and Co-repressors
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Eukaryotic Transcription Inhibitors
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...


